ACLX
Price
$89.69
Change
-$0.31 (-0.34%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
5.18B
98 days until earnings call
Intraday BUY SELL Signals
LGND
Price
$206.08
Change
-$0.97 (-0.47%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
4.06B
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACLX vs LGND

Header iconACLX vs LGND Comparison
Open Charts ACLX vs LGNDBanner chart's image
Arcellx
Price$89.69
Change-$0.31 (-0.34%)
Volume$13.7K
Capitalization5.18B
Ligand Pharmaceuticals
Price$206.08
Change-$0.97 (-0.47%)
Volume$2.25K
Capitalization4.06B
ACLX vs LGND Comparison Chart in %
ACLX
Daily Signal:
Gain/Loss:
LGND
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACLX vs. LGND commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and LGND is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ACLX: $89.90 vs. LGND: $207.05)
Brand notoriety: ACLX and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 150% vs. LGND: 123%
Market capitalization -- ACLX: $5.18B vs. LGND: $4.06B
ACLX [@Biotechnology] is valued at $5.18B. LGND’s [@Biotechnology] market capitalization is $4.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileLGND’s FA Score has 2 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • LGND’s FA Score: 2 green, 3 red.
According to our system of comparison, LGND is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while LGND’s TA Score has 3 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 4 bearish.
  • LGND’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than LGND.

Price Growth

ACLX (@Biotechnology) experienced а -0.37% price change this week, while LGND (@Biotechnology) price change was -0.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

ACLX is expected to report earnings on Feb 26, 2026.

LGND is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($5.18B) has a higher market cap than LGND($4.06B). LGND YTD gains are higher at: 92.329 vs. ACLX (16.899). LGND has higher annual earnings (EBITDA): -45.94M vs. ACLX (-179.78M). ACLX has more cash in the bank: 453M vs. LGND (255M). LGND has less debt than ACLX: LGND (5.74M) vs ACLX (52.5M). LGND has higher revenues than ACLX: LGND (188M) vs ACLX (57M).
ACLXLGNDACLX / LGND
Capitalization5.18B4.06B128%
EBITDA-179.78M-45.94M391%
Gain YTD16.89992.32918%
P/E RatioN/A90.78-
Revenue57M188M30%
Total Cash453M255M178%
Total Debt52.5M5.74M914%
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXLGND
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
78%
Bearish Trend 6 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signal:
Gain/Loss:
LGND
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OARDX27.860.14
+0.51%
Invesco Rising Dividends A
PEIYX38.960.01
+0.03%
Putnam Large Cap Value Y
NIQCX14.18N/A
N/A
Neuberger Berman International Eq C
LCILX28.07N/A
N/A
ClearBridge Sustainability Leaders IS
HNCTX21.72N/A
N/A
Hartford International Growth R5

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-0.38%
CGON - ACLX
56%
Loosely correlated
+0.16%
BEAM - ACLX
53%
Loosely correlated
-4.24%
NUVL - ACLX
52%
Loosely correlated
+2.71%
ROIV - ACLX
52%
Loosely correlated
-0.88%
XNCR - ACLX
52%
Loosely correlated
-1.62%
More

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with AGIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-0.47%
AGIO - LGND
49%
Loosely correlated
-50.89%
AXON - LGND
49%
Loosely correlated
-0.50%
ROIV - LGND
47%
Loosely correlated
-0.88%
CRSP - LGND
47%
Loosely correlated
-5.12%
ACLX - LGND
47%
Loosely correlated
-0.38%
More